Correction to: Scientific Reports https://doi.org/10.1038/s41598-017-05029-1, published online 06 July 2017
The Acknowledgements section in this Article is incomplete.
“The authors thank Camilla Skånstrøm Dall and Tina Maria Estrup Axen for technical assistance. This project was supported by Advokat Bent Thorbergs Fond.”
should read:
“The authors thank Camilla Skånstrøm Dall and Tina Maria Estrup Axen for technical assistance. This project was supported by Advokat Bent Thorbergs Fond. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 642720.”
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Appel, C.K., Gallego-Pedersen, S., Andersen, L. et al. Author Correction: The Src family kinase inhibitor dasatinib delays pain-related behaviour and conserves bone in a rat model of cancer-induced bone pain. Sci Rep 9, 7399 (2019). https://doi.org/10.1038/s41598-019-43721-6
Published:
DOI: https://doi.org/10.1038/s41598-019-43721-6
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
